Yi Hao Wong

Broadly neutralizing and protective nanobodies against SARS-CoV-2 Omicron subvariants BA.1, BA.2, and BA.4/5 and diverse sarbecoviruses

Mingxi Li, Yifei Ren, Zhen Qin Aw et al. · Nature Communications · 2022 · 75 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

Infection with wild-type SARS-CoV-2 elicits broadly neutralizing and protective antibodies against omicron subvariants

Bin Ju, Qi Zhang, Ziyi Wang et al. · Nature Immunology · 2023 · 52 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

SARS-CoV-2 Omicron Variants Reduce Antibody Neutralization and Acquire Usage of Mouse ACE2

Ruoke Wang, Qi Zhang, Rui Zhang et al. · Frontiers in Immunology · 2022 · 31 citations · Full text

Pharmacy, Immunology, Infectious Diseases +16

AAV-CRISPR-Cas13 eliminates human enterovirus and prevents death of infected mice

Choong Tat Keng, Thinesshwary Yogarajah, Regina Ching Hua Lee et al. · EBioMedicine · 2023 · 22 citations · Full text

Life Sciences, Infectious Diseases, Molecular Biology +17

The host-targeting compound peruvoside has a broad-spectrum antiviral activity against positive-sense RNA viruses

Kan Xing Wu, Thinesshwary Yogarajah, Marcus Wing Choy Loe et al. · Acta Pharmaceutica Sinica B · 2023 · 14 citations · Full text

Life Sciences, Biology, Microbiology +17